Blog – Page 2 – mrcm.org.uk

Professor Richardson elected as BSMM president

Posted on 16th September 2022 by Beth

“ I feel very honoured to be elected as President, having been a BSMM member for 50 years”, and it

Come and work with us! Apply by 14 Aug

Posted on 5th August 20225th August 2022 by Beth

Vacancy for a senior biomedical scientist (band 7, permanent) with experience in microbiology and quality management

Dr Riina Richardson appointed as Chair of the working group responsible for UK standards for bacteriological, mycological, and parasitological investigations.

Posted on 20th July 202120th July 2021 by Lauren Amphlett

Congratulations to Dr Riina Richardson on her appointment as the new Chair of the UK Standards for Microbiology Investigations (UK

MRCM Staff Nominated for STAR Award

Posted on 28th June 202128th June 2021 by Lauren Amphlett

MFT’s Clinical and Scientific Services (CSS) STAR awards aim to recognise the very best of CSS and celebrate the incredible

How MRCM has adapted to changes during COVID-19 & how we test for possible fungal superinfections

Posted on 26th November 202026th November 2020 by MRCM

One of the hottest topics in medical mycology this year has been how often COVID-19 is associated with fungal superinfections,

How we use pyrosequencing to detect azole resistance genes in Aspergillus fumigatus

Posted on 13th July 202016th November 2020 by MRCM

Pyrosequencing in practice in Journal of Antimicrobial Chemotherapy: Novak-Frazer et al (2020) Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing

Dr Rautemaa-Richardson helps develop new BASHH guidelines for vulvovaginal candidiasis

Posted on 24th October 201929th June 2020 by MRCM

Dr Riina Rautemaa-Richardson of MRCM was recently an author on the new British Association for Sexual Health and HIV (BASHH)

Importance of GM-BAL screening for invasive pulmonary aspergillosis in liver disease patients

Posted on 21st September 201921st November 2019 by MRCM

Invasive pulmonary aspergillosis (IPA) is a well-known risk for severely immunocompromised patients; in recent years, however, the infection has been

LDBio’s rapid Aspergillus IgG screening kit is sensitive (92%) and specific (98%) for chronic pulmonary aspergillosis

Posted on 5th July 201921st November 2019 by MRCM

A new screening test kit will speed up diagnosis of chronic pulmonary aspergillosis (CPA) say researchers from the University of

Comparison of three MALDI-ToF libraries (MSI, Bruker, NIH) for identification of filamentous fungi

Posted on 12th March 201921st November 2019 by MRCM

MALDI-ToF MS is a mass spectrometry technique that has revolutionised identification of bacteria in clinical samples, but whose use for filamentous

News from MRCM